You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 19, 2026

ORTHO-NOVUM 1 Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Ortho-novum 1, and when can generic versions of Ortho-novum 1 launch?

Ortho-novum 1 is a drug marketed by Ortho Mcneil Pharm, Janssen Pharms, and Ortho Mcneil Janssen. and is included in six NDAs.

The generic ingredient in ORTHO-NOVUM 1 is mestranol; norethindrone. There are eleven drug master file entries for this compound. Additional details are available on the mestranol; norethindrone profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for ORTHO-NOVUM 1?
What are the global sales for ORTHO-NOVUM 1?
What is Average Wholesale Price for ORTHO-NOVUM 1?

Summary for ORTHO-NOVUM 1

US Patents:	0
Applicants:	3
NDAs:	6

US Patents and Regulatory Information for ORTHO-NOVUM 1

+ Get email alerts for changes to this table

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ortho Mcneil Pharm	ORTHO-NOVUM 1/35-21	ethinyl estradiol; norethindrone	TABLET;ORAL-21	017489-002	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Get Started Free	⤷ Get Started Free				⤷ Get Started Free
Ortho Mcneil Pharm	ORTHO-NOVUM 10-21	mestranol; norethindrone	TABLET;ORAL-21	012728-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Get Started Free	⤷ Get Started Free				⤷ Get Started Free
Ortho Mcneil Janssen	ORTHO-NOVUM 1/50 28	mestranol; norethindrone	TABLET;ORAL-28	016709-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Get Started Free	⤷ Get Started Free				⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.